Not available
Quote | Ardelyx Inc. (NASDAQ:ARDX)
Last: | $5.62 |
---|---|
Change Percent: | -1.09% |
Open: | $5.55 |
Close: | $5.62 |
High: | $5.755 |
Low: | $5.44 |
Volume: | 3,952,325 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Ardelyx Inc. (NASDAQ:ARDX)
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx ( NASDAQ: ARDX ) stated Thursday it has signed a financing deal with HealthCare Royalty Partners to receive up to $20M on the the sale of its future royalties and sales milestones from Kyowa Kirin. Kyowa Kirin is Ardelyx' collaboration partner in Japan fo...
Message Board Posts | Ardelyx Inc. (NASDAQ:ARDX)
Subject | By | Source | When |
---|---|---|---|
$ARDX Are we heading down to the daily | TripTrap | investorshub | 04/28/2023 2:08:33 PM |
1 year chart. You don't even need | Cosa | investorshub | 04/27/2023 9:07:48 PM |
Benny $ARDX is a BP buyout candidate like | Whalatane | investorshub | 04/22/2023 10:16:59 PM |
Agree. It looks fabulous! Would | Cosa | investorshub | 04/19/2023 8:28:20 PM |
If an offering occurs after approval and is, | Benny450 | investorshub | 04/19/2023 4:55:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...